Cargando…

Drug-Induced Parkinsonism

Drug-induced parkinsonism (DIP) is the second-most-common etiology of parkinsonism in the elderly after Parkinson's disease (PD). Many patients with DIP may be misdiagnosed with PD because the clinical features of these two conditions are indistinguishable. Moreover, neurological deficits in pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shin, Hae-Won, Chung, Sun Ju
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Neurological Association 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3325428/ https://www.ncbi.nlm.nih.gov/pubmed/22523509 http://dx.doi.org/10.3988/jcn.2012.8.1.15

Ejemplares similares

Prevalence and incidence of Parkinson’s disease and drug-induced parkinsonism in Korea
por: Han, Sola, et al.
Publicado: (2019)

Clinical Aspects of the Differential Diagnosis of Parkinson’s Disease and Parkinsonism
por: Shin, Hae-Won, et al.
Publicado: (2022)

Long-term Effects of Bilateral Subthalamic Deep Brain Stimulation on Postural Instability and Gait Difficulty in Patients with Parkinson’s Disease
por: Shin, Hae-Won, et al.
Publicado: (2020)

Shared functional neural substrates in Parkinson's disease and drug-induced parkinsonism: association with dopaminergic depletion
por: Oh, Se Won, et al.
Publicado: (2020)

Human Genetic Variation and Parkinson’s Disease
por: Chung, Sun Ju
Publicado: (2010)

Neuroimaging Techniques in Differentiating Parkinson’s Disease from Drug-Induced Parkinsonism: A Comprehensive Review
por: Pitton Rissardo, Jamir, et al.
Publicado: (2023)

Oxidative stress and cellular pathologies in Parkinson’s disease
por: Puspita, Lesly, et al.
Publicado: (2017)

Treatment Changes and Prognoses in Patients with Incident Drug-Induced Parkinsonism Using a Korean Nationwide Healthcare Claims Database
por: Kim, Siin, et al.
Publicado: (2023)

Hyperhomocysteinemia in Patients with Parkinson’s Disease and Relationship to Vitamin B Level
por: Shin, Hae-Won, et al.
Publicado: (2009)

Syndromic Approach to Parkinson's Disease: Role of Functional Imaging
por: Lee, Chong Sik, et al.
Publicado: (2006)

Professional ethics in complementary and alternative medicines in management of Parkinson’s disease
por: Kim, Hee Jin, et al.
Publicado: (2016)

Decreased thalamic monoamine availability in drug-induced parkinsonism
por: Oh, Yoon-Sang, et al.
Publicado: (2022)

Updated Perspectives on the Management of Drug-Induced Parkinsonism (DIP): Insights from the Clinic
por: Feldman, Matthew, et al.
Publicado: (2022)

Neuropsychiatric Symptoms and Quality of Life in Patients With Adult-Onset Idiopathic Focal Dystonia and Essential Tremor
por: Lee, Sangjin, et al.
Publicado: (2020)

Cardiovascular Autonomic Dysfunction in Patients with Drug-Induced Parkinsonism
por: Kim, Joong-Seok, et al.
Publicado: (2017)

Drug therapy in patients with Parkinson’s disease
por: Müller, Thomas
Publicado: (2012)

E. C. T. AND DRUG INDUCED PARKINSONISM
por: Gangadhar, B.N., et al.
Publicado: (1983)

Clinical features of drug-induced Parkinsonism
por: Shiraiwa, Nobuko, et al.
Publicado: (2018)

Author Correction: Decreased thalamic monoamine availability in drug-induced parkinsonism
por: Oh, Yoon-Sang, et al.
Publicado: (2022)

Drug-induced Parkinsonism: A strong predictor of idiopathic Parkinson’s disease
por: Jeong, Sohyun, et al.
Publicado: (2021)

Toxin-Induced and Genetic Animal Models of Parkinson's Disease
por: Hisahara, Shin, et al.
Publicado: (2010)

Neuroprotection or Neurotoxicity of Illicit Drugs on Parkinson’s Disease
por: Ferreira, Carla, et al.
Publicado: (2020)

Clinical implication of stimulation-induced dyskinaesia in globus pallidus deep brain stimulation for advanced Parkinson’s disease
por: Lee, Seung Hyun, et al.
Publicado: (2022)

Patient-Derived Induced Pluripotent Stem Cell-Based Models in Parkinson’s Disease for Drug Identification
por: Kouroupi, Georgia, et al.
Publicado: (2020)

Manganese-Induced Parkinsonism and Parkinson’s Disease: Shared and Distinguishable Features
por: Kwakye, Gunnar F., et al.
Publicado: (2015)

Trends in the Prevalence of Drug-Induced Parkinsonism in Korea
por: Byun, Ji-Hye, et al.
Publicado: (2019)

Hand Tremor Questionnaire: A Useful Screening Tool for Differentiating Patients with Hand Tremor between Parkinson's Disease and Essential Tremor
por: Kwon, Kyum-Yil, et al.
Publicado: (2018)

GBA1 Variants and Parkinson’s Disease: Paving the Way for Targeted Therapy
por: Huh, Young Eun, et al.
Publicado: (2023)

Update on CSF Biomarkers in Parkinson’s Disease
por: Kwon, Eun Hae, et al.
Publicado: (2022)

Translational molecular imaging and drug development in Parkinson’s disease
por: Haider, Ahmed, et al.
Publicado: (2023)

Systematic Review on Parkinson’s Disease Medications, Emphasizing on Three Recently Approved Drugs to Control Parkinson’s Symptoms
por: Sivanandy, Palanisamy, et al.
Publicado: (2021)

Drug repurposing strategies of relevance for Parkinson’s disease
por: Fletcher, Edward J. R., et al.
Publicado: (2021)

Recent Advances in Drug Therapy for Parkinson's Disease
por: Murakami, Hidetomo, et al.
Publicado: (2022)

Psychiatric Manifestation in Patients with Parkinson's Disease
por: Han, Ji Won, et al.
Publicado: (2018)

Retinal Thickness and Its Interocular Asymmetry Between Parkinson’s Disease and Drug-Induced Parkinsonism
por: Suh, Wool, et al.
Publicado: (2023)

Bifrontal ECT for drug-induced psychosis in Parkinson's disease
por: Muralidharan, K., et al.
Publicado: (2011)

S4. ASYMMETRIC DRUG-INDUCED PARKINSONISM IS RELATED TO PSYCHOPATHOLOGY
por: Pieters, Lydia, et al.
Publicado: (2018)

Drug-Induced Parkinsonism: Too Many Cooks in the Kitchen
por: Liotta, Mark, et al.
Publicado: (2023)

HLA Association with Drug-Induced Adverse Reactions
por: Fan, Wen-Lang, et al.
Publicado: (2017)

Promising drug targets and associated therapeutic interventions in Parkinson’s disease
por: Rai, Sachchida Nand, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4igsofijv005bpea58kb7hb473